Navigation Links
Sam Safran wins EPJE -- Pierre-Gilles De Gennes Lecture Prize
Date:7/2/2010

Sam Safran, a professor at the Weizmann Institute in Israel, has been chosen as the recipient of the first EPJE - Pierre-Gilles De Gennes Lecture Prize. The prize, accompanied by 1,000, is being awarded by Springer's European Physical Journal E (EPJE). Safran is the author of numerous articles in this journal.

The EPJE - Pierre-Gilles De Gennes Lecture Prize, which was named after the Nobel laureate who founded EPJE, has been awarded to Safran to recognize his leading research in soft matter and biological physics. The prizewinner has been invited to give a lecture at the International Soft Matter Conference 2010 in Granada, Spain. The prize will be presented to Safran at the beginning of his plenary talk on 6 July 2010.

In addition to serving as a professor at the Wiezmann Institute, Safran also served as Vice President and Dean of its Graduate School. From 1980-1990 he was at the Exxon Corporate Research Labs where he worked on the theory of soft matter with a focus on the structure and phase behavior of oil-water-surfactant dispersions. His recent research interests have extended soft matter concepts to treat biological membranes and cells. Safran is a recipient of the Beller Lectureship Award of the American Physical Society and the Lectureship Award of the Japanese Chemical Society.


'/>"/>

Contact: Joan Robinson
joan.robinson@springer.com
49-622-148-78130
Springer
Source:Eurekalert

Page: 1

Related biology news :

1. SAFRAN to Acquire Motorolas Biometrics Business
2. Dr. George Stark receives 2011 Herbert Tabor/Journal of Biological Chemistry Lectureship from ASBMB
3. Public lecture to explore solutions to the food challenge
4. Public lecture at UC Riverside to highlight Californias environment
5. Vilcek Prize lecture
6. UC Riverside lecture: Climate change, bark beetles, environmental markets and sustainability
7. A rocking good lecture
8. Nobel Laureate Roger Tsien to present national lecture at the Biophysical Society meeting
9. Nobel laureate claims the 2010 Herbert Tabor Lectureship
10. Plenary lecturers share science and policy perspectives
11. Evolution of hyperactivity is focus of free public lecture at UC Riverside
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/7/2017)... , March 7, 2017   HireVue , ... top global companies identify the best talent, faster, today ... Chief Sales Officer (CSO) and Diana Kucer ... round out a seasoned executive team poised to drive continued ... building on a year of record bookings in 2017. ...
(Date:3/2/2017)... , March 2, 2017 Australian stem ... (ASX: CYP), has signed an agreement with the ... the Monash Biomedicine Discovery Institute and Department of Pharmacology ... conduct a further preclinical study to support the use ... of asthma.  Asthma is a chronic, ...
(Date:2/27/2017)... Feb. 27, 2017   Strategic Cyber Ventures , ... has led a $3.5 million investment in  Polarity , ... Cyber Ventures is DC based and is led by ... Thomas . Ron Gula , also a longtime ... participated in this series A round of funding. This ...
Breaking Biology News(10 mins):
(Date:3/28/2017)... -- The National Pharmaceutical Council (NPC) today announced that Ipsen ... as its newest member. David Cox , PhD, ... America ), will serve as his company,s representative ... to have Ipsen and Dr. Cox join NPC as ... welcome their insights in helping us identify and address ...
(Date:3/28/2017)... ... March 28, 2017 , ... LabKey and collaborator Just Biotherapeutics, ... solution, LabKey Biologics . Built in collaboration with Just and designed with ... provides drug research teams tools for biological entity registration, assay data integration, and ...
(Date:3/28/2017)... , March 28, 2017 /PRNewswire/ -RepliCel Life Sciences Inc. (OTCQB: ... to report compelling safety and clinical data from its phase ... 1 collagen-expressing, hair follicle-derived fibroblasts (RCT-01) as a treatment for ... ... a complete safety profile at 6 months and showed no ...
(Date:3/27/2017)... ... March 27, 2017 , ... IsoPlexis Corporation ... cancer, autoimmune disease and more through a single-cell precision engineering platform, today announced ... platform developed in the laboratory of Dr. James Heath at the California ...
Breaking Biology Technology: